 The PROOF Centre welcomes Dr. David Brener as its new Chief Business Development Officer.
The PROOF Centre welcomes Dr. David Brener as its new Chief Business Development Officer.
Dr. Brener is a leader in the identification, development, management and delivery of innovative vehicles enabling R&D commercialization and knowledge translation in both the private and …

 Two Networks of Centres of Excellence (NCEs), the Centre of Excellence for the Prevention of Organ Failure (PROOF Centre) and AllerGen NCE (Allergy, Genes and Environment Network of Centres of Excellence), are working together to develop blood tests that will …
Two Networks of Centres of Excellence (NCEs), the Centre of Excellence for the Prevention of Organ Failure (PROOF Centre) and AllerGen NCE (Allergy, Genes and Environment Network of Centres of Excellence), are working together to develop blood tests that will … The PROOF Centre and IO Informatics are putting their heads together to develop new tools for clinicians to address chronic heart, lung and kidney disease.
The PROOF Centre and IO Informatics are putting their heads together to develop new tools for clinicians to address chronic heart, lung and kidney disease. The PROOF Centre has granted HTG Molecular Diagnostics exclusive rights to commercialize PROOF Centre-developed gene expression blood tests for the prognosis of patients with Chronic Obstructive Pulmonary Disease (COPD) who will experience frequent exacerbations (“lung attacks”).
The PROOF Centre has granted HTG Molecular Diagnostics exclusive rights to commercialize PROOF Centre-developed gene expression blood tests for the prognosis of patients with Chronic Obstructive Pulmonary Disease (COPD) who will experience frequent exacerbations (“lung attacks”).